Stem Cell Research and News: Virginia
<-- Back To RegionsCitizens' Initiative Effort Launched to Protect Stem Cell Research and Cures in Missouri
Statewide Ballot Measure is the First in U.S. Designed to Protect Patients' Rights to Receive Stem Cell Therapies and Cures JEFFERSON CITY, Mo., Oct. 11 - A coalition of patient advocacy groups, medical organizations and concerned citizens today launched an...
Posted in Today's Stem Cell Research on November 3, 2005 01:29 PM
MultiCell Technologies Awarded Pilot Grant for Study of Type 1 Diabetes Therapeutic
LINCOLN, R.I. – September 14, 2005 – MultiCell Technologies, Inc. (OTCBB: MCET), a leading adult stem cell company and a supplier of immortalized non-tumorigenic human hepatocytes for drug discovery applications, announced today that it has been awarded a pilot grant...
Posted in Today's Stem Cell Research on September 22, 2005 05:42 PM
Cytori Therapeutics Demonstrates Adipose-Derived Adult Stem and Regenerative Cells Enhance Cardiac Function in Preclinical Study
Data Featured in One of Four Cytori Presentations at Annual Adipose Biology Meeting San Diego, CA, September 12, 2005 - Cytori Therapeutics, Inc. (Frankfurt: XMP), today announced preclinical results that support therapeutic opportunities for adult stem and regenerative cells derived...
Posted in Today's Stem Cell Research on September 22, 2005 04:19 PM
Stem Cell Media Advisory: Leaders in Adult Stem Cells Derived from Fat to Hold News Conference
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Sep 8, 2005 - The growing therapeutic role of adult stem cells derived from adipose, also known as fat tissue, will be highlighted at a news conference to be held Monday, September 12, 2005, 12:30-1:45 pm Eastern...
Posted in Today's Stem Cell Research on September 9, 2005 03:24 PM
MultiCell Technologies Announces New Employment Agreement With Dr. Ronald Faris, Ph.D.
LINCOLN, R.I.-- May 31, 2005--MultiCell Technologies, Inc. (OTCBB: MCET), a leading supplier of immortalized non-tumorigenic human hepatocytes as pharmaceutical candidate optimization tools, announced that Ronald Faris, Ph.D., Senior Vice President and Chief Science Officer of the Company, has signed a...
Posted in Today's Stem Cell Research on June 3, 2005 05:04 PM
Serologicals Corporation to Present at Banc of America 2005 Healthcare Conference
Serologicals Corporation (Nasdaq/NM: SERO) today announced that it is scheduled to give an investor presentation at the Banc of America 2005 Healthcare Conference on May 17, 2005. Bud Ingalls, Vice President, Finance and Chief Financial Officer for Serologicals Corporation, will...
Posted in Today's Stem Cell Research on May 13, 2005 01:45 PM
Report Proposes Structure for National Network of Cord Blood Stem Cell Banks
WASHINGTON -- To achieve a more cohesive national system for storing and distributing lifesaving stem cells derived from umbilical cord blood, the U.S. Department of Health and Human Services should establish a new National Cord Blood Policy Board to set...
Posted in Today's Stem Cell Research on April 15, 2005 02:53 PM
Growing Coalition Opposes Ban on Stem Cell Research
- Hundreds of Missouri Medical Experts, Patient Advocates, Clergy, and Civic and Business Leaders Join Effort to Protect Stem Cell Research JEFFERSON CITY, Mo., April 6 /PRNewswire/ -- Supporters of stem cell research announced today that hundreds of prominent medical...
Posted in Today's Stem Cell Research on April 7, 2005 11:25 AM
US Patent Office Rejects PharmaStem Cord Blood Stem Cell Patents
ThermoGenesis Corp. (Nasdaq: KOOL), a supplier of cryogenic devices used by cord blood banks, and NETCORD, the leading international network of public cord blood banks, today announced that the U.S. Patent Office (PTO) has reexamined U.S. Patent 5,192,553 (Patent '553)...
Posted in Today's Stem Cell Research on March 1, 2005 07:47 PM
Virgina: State House and Senate Passes Stem Cell Bill
The Virgina State House and Senate have passed a bill that would create a new stem-cell research fund in memory of actor Christopher Reeve. The measure, which does not apply to embryonic stem-cell research, passed in the House 76-22 vote...
Posted in Today's Stem Cell Research on February 23, 2005 12:36 PM
Cord Blood Bank List
With stem cell research so closely tied to Umbilical Cord Blood, we thought it a good idea to get a somewhat comprehensive list of Cord Blood Banks put together. Additionally, since we have been tracking a many stem cell research...
Posted in Today's Stem Cell Research on February 22, 2005 01:55 PM
Virginia Panel approves subsidy for stem-cell research
Over the objections of conservatives, a Virginia Senate panel yesterday approved a proposal for state-subsidized stem-cell research. "If it's all right for Nancy Reagan and her family . . . it's all right for me," said Sen. H. Russell Potts...
Posted in Today's Stem Cell Research on February 5, 2005 09:42 PM
Stem Cell Research Progress Regarding Diabetes
Several recent studies underline stem cell research as a basis for critically-needed therapies for type 1 diabetes. Insulin-producing cells have already been created using embryonic stem cells from mice as well as in preliminary studies using embryonic cell lines from...
Posted in Today's Stem Cell Research on January 25, 2005 06:00 PM
Waist Product = Medical Value?
Dr. Robert Ersek, a 66-year-old plastic surgeon, invited reporters to his Texas operating room and, in front of their cameras, proceeded to liposuction himself...which must not be fun really .. Read On...
Posted in Today's Stem Cell Research on December 10, 2004 09:12 AM